Nuzenio

Reduce Mace

Reduce Mace news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 6 latest news signals 6 publisher sources 100/100 entity strength

Latest news

Timeline

Fri, 07 Aug 2026 00:54:43 GMTMACE Risk May Be Reduced with GLP-1 Drug in High-Risk Patients - insideprecisionmedicine.com
Mon, 03 Aug 2026 17:05:08 GMTZEUS Trial: Ziltivekimab Fails to Reduce MACE in ASCVD Patients - TCTMD.com
Fri, 31 Jul 2026 15:22:14 GMTNovo Nordisk’s mAb for MACE risk reduction fails in Phase III trial - Clinical Trials Arena
Fri, 31 Jul 2026 12:42:48 GMTZiltivekimab Fails to Reduce MACE Risk in Phase 3 ZEUS Trial - HCPLive
Fri, 31 Jul 2026 11:39:14 GMTNovo Nordisk shares dive after heart medicine fails trial, dealing another blow to its pipeline - CNBC
Fri, 31 Jul 2026 07:00:00 GMTZiltivekimab shows no MACE risk reduction in ZEUS trial for Novo Nordisk (NVO) - Stock Titan

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Reduce Mace.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

6 distinct publisher/source names are currently connected to this entity page.